Skip to content

Clinical trials

Phase 2 Carcinoma, Hepatocellular trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2 Country / region: Italy Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20073
20081
20093
20101
20112
20123
20132
20141
20151
20171
20181
20192
20201
20213
20221
20235
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Active, not recruiting4
Terminated4
Recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer7
Istituto Clinico Humanitas3
Azienda Ospedaliera di Padova2
4SC AG1
AGC Biologics S.p.A.1
AbbVie1
Astellas Pharma Inc1
AstraZeneca1
BeiGene1
Boston Scientific Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular35
Liver Neoplasms5
Colorectal Neoplasms3
Neoplasms3
Ovarian Neoplasms3
Biliary Tract Neoplasms2
Cholangiocarcinoma2
Liver Diseases2
Stomach Neoplasms2
Urinary Bladder Neoplasms2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.